At Quibim, we are excited to showcase our latest news
at RSNA 2024
Join us for this groundbreaking edition!
Explore the newest medical imaging industry advancements and immerse yourself in pioneering data research, top-tier educational sessions, and exceptional networking opportunities with radiologists and industry leaders from around the globe.
QP-Prostate® helps radiologists detect more than 90% of cancer*
Our software offers a sensitivity of 90.4% per 100 cases in the detection of prostate tumors, compared to 79.8% of detections made by radiologists when not using the tool, according to the study conducted in collaboration with Massachusetts General Hospital in Boston.QP-Brain®: The go-to solution in automated MRI analysis
The AI tool that accurately differentiates grey and white matter hyperintensities, cerebrospinal fluid, and analyzing 132 distinct brain regions (L/R). QP-Brain provides comprehensive information, segmenting cortical and subcortical structures.Want to know more about what we do at Quibim?
Tests such as biopsies can provide incomplete data, and it is in this context that radiomics becomes important. But what exactly is radiomics? Explore how this advanced approach transcends conventional medical imaging, offering insights into its revolutionary impact on patient care.
Visit booth #5115 to talk to our team and request a demo to explore how our products are changing the radiologist pathway.
About us
At Quibim, we design pioneering tools that unlock imaging data to improve patient outcomes.
Our main purpose is the application of AI techniques to medical images from MRI, CT, PET to unlock new data which can be transformed into actionable predictions for life sciences and providers. Our business model is based on a platform marketed through SaaS for hospitals and value-based partnerships in life sciences that help to identify new market needs and create new algorithms.